MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

Search

Vivani Medical

Fechado

1.48 6.47

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.35

Máximo

1.49

Indicadores-chave

By Trading Economics

Funcionários

37

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+185.71% upside

Dividendos

By Dow Jones

Próximos Ganhos

11 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

11M

64M

Abertura anterior

-4.99

Fecho anterior

1.48

Vivani Medical Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de jul. de 2025, 22:07 UTC

Grandes Movimentos do Mercado

Trade Desk Rises on S&P 500 Inclusion

14 de jul. de 2025, 17:06 UTC

Grandes Movimentos do Mercado

Crypto Assets Rally Ahead of Possible U.S. Legislation

14 de jul. de 2025, 16:47 UTC

Aquisições, Fusões, Aquisições de Empresas

NatWest to Sell Stake in Permanent TSB

14 de jul. de 2025, 23:46 UTC

Conversa de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

14 de jul. de 2025, 23:38 UTC

Conversa de Mercado

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14 de jul. de 2025, 23:37 UTC

Conversa de Mercado

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14 de jul. de 2025, 23:29 UTC

Conversa de Mercado

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14 de jul. de 2025, 23:29 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

14 de jul. de 2025, 23:02 UTC

Ganhos

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14 de jul. de 2025, 23:02 UTC

Ganhos

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14 de jul. de 2025, 23:02 UTC

Ganhos

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14 de jul. de 2025, 23:01 UTC

Ganhos

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14 de jul. de 2025, 23:01 UTC

Ganhos

China Vanke Expects 1H Loss to Widen >000002.SZ

14 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

14 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

14 de jul. de 2025, 20:07 UTC

Conversa de Mercado

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14 de jul. de 2025, 20:05 UTC

Conversa de Mercado

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14 de jul. de 2025, 19:11 UTC

Conversa de Mercado

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14 de jul. de 2025, 19:09 UTC

Conversa de Mercado

Gold Breaks a 3-Day Win Streak -- Market Talk

14 de jul. de 2025, 18:59 UTC

Conversa de Mercado

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14 de jul. de 2025, 18:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14 de jul. de 2025, 18:25 UTC

Conversa de Mercado

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14 de jul. de 2025, 18:25 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

14 de jul. de 2025, 16:59 UTC

Conversa de Mercado

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14 de jul. de 2025, 16:53 UTC

Ações em Alta

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 de jul. de 2025, 16:27 UTC

Conversa de Mercado

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14 de jul. de 2025, 16:20 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

14 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

14 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

14 de jul. de 2025, 16:12 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Comparação entre Pares

Variação de preço

Vivani Medical Previsão

Preço-alvo

By TipRanks

185.71% parte superior

Previsão para 12 meses

Média 4 USD  185.71%

Máximo 4 USD

Mínimo 4 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Vivani Medical - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

2

Comprar

0

Manter

0

Vender

Informação Financeira

$

Sobre Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.